Log In
person
Exelixis Inc
EXEL
summarize
3 total product lines
calendar_month
Revenue as of 12/29/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Collaboration Revenues |
Active Pharmaceutical Ingredient Licensing to Pharma Manufacturers
These companies develop APIs and license their patented technology to pharmaceutical drug manufacturers.
|
0.18B | 9.76% |
| Collaboration Revenues |
Contract Research for Drug Manufacturers
These companies do contract services for biotech and pharmaceutical companies.
|
0.02B | 1.24% |
| Product Revenues |
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
|
1.63B | 89.00% |
| keyboard_arrow_down |
Collaboration Revenues
Active Pharmaceutical Ingredient Licensing to Pharma Manufacturers
|
0.18B | 9.76% |
| keyboard_arrow_right |
These companies develop APIs and license their patented technology to pharmaceutical drug manufacturers.
|
||
| keyboard_arrow_down |
Collaboration Revenues
Contract Research for Drug Manufacturers
|
0.02B | 1.24% |
| keyboard_arrow_right |
These companies do contract services for biotech and pharmaceutical companies.
|
||
| keyboard_arrow_down |
Product Revenues
Branded Pharmaceuticals (outsourced)
|
1.63B | 89.00% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of patented drugs.
|
||